Adverse Events of Oncologic Immunotherapy and Their Management
Over the past two decades, immunotherapy has emerged as a promising treatment option for patients with cancer. However, newer versions of immunotherapy, such as checkpoint inhibitors, may be associated with unusual adverse effects (AEs) that can range in severity from mild to life-threatening. Unlik...
Main Author: | Fedricker Diane Barber |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Asia-Pacific Journal of Oncology Nursing |
Subjects: | |
Online Access: | http://www.apjon.org/article.asp?issn=2347-5625;year=2019;volume=6;issue=3;spage=212;epage=226;aulast=Barber |
Similar Items
-
Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01) -
Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit
by: Adrien Joseph, et al.
Published: (2020-10-01) -
Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases
by: Jean-Matthieu L’Orphelin, et al.
Published: (2021-09-01) -
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers
by: Ina Shehaj, et al.
Published: (2024-03-01) -
Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
by: Ni Zhao, et al.
Published: (2022-08-01)